Personal information

No personal information available

Activities

Employment (1)

Boston Children's Hospital: Boston, Massachusetts, US

2017-07-01 to present | Clinical Fellow (Department of Newborn Medicine)
Employment
Source: Self-asserted source
Ravikiran M Raju

Works (14)

MEF2 is a key regulator of cognitive potential and confers resilience to neurodegeneration

Science Translational Medicine
2021-11-03 | Journal article
Contributors: Scarlett J. Barker; Ravikiran M. Raju; Noah E.P. Milman; Jun Wang; Jose Davila-Velderrain; Fatima Gunter-Rahman; Cameron C. Parro; P. Lorenzo Bozzelli; Fatema Abdurrob; Karim Abdelaal et al.
Source: check_circle
Crossref

Are Pediatric House Calls the Future? Exploring Patient Perceptions of Home-Centered Health.

Clinical pediatrics
2019-06 | Journal article
Contributors: Raju SM; Raju RM; Shumskiy I; Morenz AM; Whitney KM; Vernacchio L; Fleegler EW
Source: Self-asserted source
Ravikiran M Raju via Europe PubMed Central

The complexity of neuroinflammation at single-cell resolution.

Nature reviews. Neurology
2019-05 | Journal article
Contributors: Raju RM; Tsai LH
Source: Self-asserted source
Ravikiran M Raju via Europe PubMed Central

An Antibacterial β-Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid Biosynthesis.

Angewandte Chemie (International ed. in English)
2017-12 | Journal article
Contributors: Lehmann J; Cheng TY; Aggarwal A; Park AS; Zeiler E; Raju RM; Akopian T; Kandror O; Sacchettini JC; Moody DB et al.
Source: Self-asserted source
Ravikiran M Raju via Europe PubMed Central

Home Visits: Advancing Pediatric Training by Preserving Past Traditions.

Pediatrics
2016-08 | Journal article
Contributors: Shumskiy I; Raju RM; Tschudy MM
Source: Self-asserted source
Ravikiran M Raju via Europe PubMed Central

Inflammatory signaling in human tuberculosis granulomas is spatially organized.

Nature medicine
2016-04 | Journal article
Contributors: Marakalala MJ; Raju RM; Sharma K; Zhang YJ; Eugenin EA; Prideaux B; Daudelin IB; Chen PY; Booty MG; Kim JH et al.
Source: Self-asserted source
Ravikiran M Raju via Europe PubMed Central

Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease.

Emerging infectious diseases
2016-03-01 | Journal article
Source: Self-asserted source
Ravikiran M Raju

Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria.

mBio
2015-05-05 | Journal article
Source: Self-asserted source
Ravikiran M Raju

Post-translational regulation via Clp protease is critical for survival of Mycobacterium tuberculosis.

PLoS pathogens
2014-03-06 | Journal article
Source: Self-asserted source
Ravikiran M Raju

Bacterial proteolytic complexes as therapeutic targets.

Nature reviews. Drug discovery
2012-10-01 | Journal article
Source: Self-asserted source
Ravikiran M Raju

Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection.

PLoS pathogens
2012-02-16 | Journal article
Source: Self-asserted source
Ravikiran M Raju

The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring.

The EMBO journal
2012-01-27 | Journal article
Source: Self-asserted source
Ravikiran M Raju

MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.

Antimicrobial agents and chemotherapy
2011-10-24 | Journal article
Source: Self-asserted source
Ravikiran M Raju

Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay.

Clinical and vaccine immunology : CVI
2011-05-18 | Journal article
Source: Self-asserted source
Ravikiran M Raju